Retail & Wholesale » Retail | AmerisourceBergen Corp.

AmerisourceBergen Corp. | Income Statement

Fiscal year is October-September. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
87,959
119,569
135,962
146,850
153,144
167,940
Cost of Goods Sold (COGS) incl. D&A
85,636
116,796
132,747
143,076
148,997
163,828
Gross Income
2,323
2,773
3,215
3,774
4,147
4,111
SG&A Expense
1,334
1,587
1,908
2,091
2,129
2,460
EBIT
989
1,185
-
-
2,018
1,651
Unusual Expense
91
439
916
157
958
261
Non Operating Income/Expense
-
4
14
5
3
5
Interest Expense
75
78
112
144
149
190
Pretax Income
824
673
269
1,391
918
1,177
Income Tax
331
389
407
37
553
438
Consolidated Net Income
493
284
138
1,428
364
1,616
Net Income
493
284
138
1,428
364
1,658
Net Income After Extraordinaries
553
292
138
1,428
364
1,658
Net Income Available to Common
434
276
138
1,428
364
1,658
EPS (Basic)
1.84
1.17
0.63
6.32
1.64
7.53
Basic Shares Outstanding
231
227
218
212
218
218
EPS (Diluted)
1.84
1.17
0.63
6.32
1.64
7.53
Diluted Shares Outstanding
235
235
218
226
222
220
EBITDA
1,155
1,373
1,557
2,068
2,441
2,151
Non-Operating Interest Income
1
1
3
4
4
15

About AmerisourceBergen

View Profile
Address
1300 Morris Drive
Chesterbrook Pennsylvania 19087
United States
Employees -
Website http://www.amerisourcebergen.com
Updated 07/08/2019
AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution and Other segments. The Pharmaceutical Distribution segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.